4//SEC Filing
Alafi Christopher D 4
Accession 0001209191-19-049172
CIK 0001567514other
Filed
Sep 10, 8:00 PM ET
Accepted
Sep 11, 4:30 PM ET
Size
14.3 KB
Accession
0001209191-19-049172
Insider Transaction Report
Form 4
Alafi Christopher D
Director10% Owner
Transactions
- Purchase
Common Stock
2019-09-10$10.58/sh+320,095$3,386,605→ 4,667,030 total(indirect: By LLC) - Purchase
Common Stock
2019-09-10$8.98/sh+3,549$31,870→ 4,191,819 total(indirect: By LLC) - Purchase
Common Stock
2019-09-10$9.59/sh+155,116$1,487,562→ 4,346,935 total(indirect: By LLC) - Purchase
Common Stock
2019-09-10$11.00/sh+6,240$68,640→ 4,673,270 total(indirect: By LLC)
Holdings
- 341,223
Common Stock
- 170,000(indirect: By Trust)
Common Stock
- 503,753(indirect: By Trust)
Common Stock
Footnotes (6)
- [F1]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.97 to $8.99 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- [F2]Dr. Alafi is a managing partner of Alafi Capital Company, LLC and may be deemed to beneficially own the shares held by Alafi Capital Company, LLC. Dr. Alafi disclaims beneficial ownership of the securities held by Alafi Capital Company, LLC except to the extent of his pecuniary interest therein.
- [F3]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.00 to $9.99 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- [F4]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.00 to $10.99 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- [F5]Dr. Alafi is the Trustee of The Moshe H. Alafi and Margaret E. Alafi Generation-Skipping Trust. Dr. Alafi disclaims beneficial ownership of the securities held by the trust except to the extent of his pecuniary interest therein, if any.
- [F6]Shireen Michele Alafi is the Trustee of the Christopher D Alafi Family Trust. Dr. Alafi disclaims beneficial ownership of the securities held by the trust except to the extent of his pecuniary interest therein, if any.
Documents
Issuer
Intra-Cellular Therapies, Inc.
CIK 0001567514
Entity typeother
Related Parties
1- filerCIK 0001299430
Filing Metadata
- Form type
- 4
- Filed
- Sep 10, 8:00 PM ET
- Accepted
- Sep 11, 4:30 PM ET
- Size
- 14.3 KB